Teriparatide Injection, Solution
Product Images NDC 47781-652

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 47781-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Teriparatide Injection 250 mcg/mL (620 mcg/2.48 mL), a subcutaneous injection by Alvogen, Inc. The label includes dosing instructions of 20 mcg per dose, storage guidance to refrigerate at 2° to 8°C and not freeze, and notes that the single-patient-use pen delivers 28 subcutaneous doses. Needles are not included. The label also provides ingredient information, a toll-free number, and packaging barcodes.*

FDA Label Image

Figure-1 (Figure 1)

A line graph showing the percentage of patients with nonvertebral osteoporotic fractures over 20 months since randomization. Two lines are depicted: a dashed line for teriparatide and a solid line for placebo. The graph shows fewer fractures in the teriparatide group compared to placebo over time.*

FDA Label Image

Ifu-fig-a (Ifu Fig A)

Illustration showing the parts of the Teriparatide Injection device including the outer needle cover, inner needle cover, needle, paper tab, white cap, medicine cartridge, plunger, label, teal body, instruction window, and black injection button. It notes that needles are not included and recommends Becton, Dickinson and Company pen needles from 29 to 31 gauge for use with this device.*

FDA Label Image

Ifu-fig-b (Ifu Fig B)

An instructional illustration showing one hand holding a syringe with a capped needle and the other hand removing a protective cover from the needle. The illustration is labeled as Figure B.*

FDA Label Image

Ifu-fig-c (Ifu Fig C)

An instructional illustration showing a hand holding a teriparatide injection pen with an arrow pointing towards a human eye. The image likely demonstrates the proper direction or orientation related to the injection pen use.*

FDA Label Image

Ifu-fig-d (Ifu Fig D)

Instructional illustration labeled Figure D showing a person using two hands to remove a protective cap from the top of a teriparatide injection device. This step is part of preparing the subcutaneous injection solution for use.*

FDA Label Image

Ifu-fig-e-f (Ifu Fig E F)

Instructional illustration showing hands removing the cap of a prefilled syringe by pulling and twisting, labeled as Figure E and Figure F. The syringe is intended for subcutaneous injection of teriparatide 250 ug/mL solution.*

FDA Label Image

Ifu-fig-g (Ifu Fig G)

Instructional illustration showing the removal of the cap from the needle of a prefilled teriparatide injection pen. The diagram highlights the proper grip and motion needed to pull off the needle cover before subcutaneous administration.*

FDA Label Image

Ifu-fig-h (Ifu Fig H)

An instructional illustration showing two hands holding a pen-like injector device for subcutaneous injection. The device features a colored section with a triangular play button symbol and an arrow indicating the direction to pull or slide a black cap or cover off the injector to prepare for use.*

FDA Label Image

Ifu-fig-i (Ifu Fig I)

An instructional diagram showing part of a device with labels identifying the red stripe, yellow shaft, and instruction window on the device, meant to help users properly understand its components.*

FDA Label Image

Ifu-fig-j (Ifu Fig J)

Illustration showing the removal of a protective cap from the needle of a teriparatide injection pen. The image demonstrates how to hold the pen and pull the cap off before subcutaneous administration.*

FDA Label Image

Ifu-fig-k (Ifu Fig K)

An instructional illustration labeled Figure K showing a hand holding a teriparatide injection pen vertically, with the needle placed subcutaneously at the injection site on skin. A downward arrow indicates the direction to insert the needle during subcutaneous administration.*

FDA Label Image

Ifu-fig-l (Ifu Fig L)

An instructional illustration showing a hand pressing down on a syringe-like injector for teriparatide injection solution. The image depicts subcutaneous injection preparation with emphasis on the pressing action as indicated by a downward arrow and the word 'PRESS' above the hand.*

FDA Label Image

Ifu-fig-m (Ifu Fig M)

An instructional illustration showing a hand holding a teriparatide injection pen with the needle inserted into the skin. The word 'HOLD' is displayed above, and a numbered scale from 1 to 5 is shown below, indicating a step in the injection process.*

FDA Label Image

Ifu-fig-n (Ifu Fig N)

Instructional illustration showing a hand holding a teriparatide injection pen, lifting it upward from the base cap prior to use. The diagram is labeled 'LIFT' and demonstrates the step for preparing the subcutaneous injection device.*

FDA Label Image

Ifu-fig-o (Ifu Fig O)

An instructional illustration labeled 'Figure O' showing a close-up of a teal-colored device with a yellow button featuring a red play icon. A green checkmark is overlayed, indicating the correct positioning or action related to the device's use.*

FDA Label Image

Ifu-fig-p-q (Ifu Fig P Q)

An instructional illustration demonstrating the preparation of an injection pen. The top part labeled 'Scoop Up' shows a hand removing a protective cap from the pen. The bottom part labeled 'Figure P' and 'Figure Q' depicts hands securing or removing another component from the pen. The artwork uses arrows to guide the steps.*

FDA Label Image

Ifu-fig-r (Ifu Fig R)

An instructional illustration labeled as Figure R showing a person holding a medical syringe with one hand and using the other hand to twist or remove a cap or cover from the syringe's tip. The arrow indicates the direction of rotation which is clockwise.*

FDA Label Image

Ifu-fig-s (Ifu Fig S)

An instructional diagram showing a hand holding a teriparatide injection syringe, demonstrating how to pull or slide a component away from the syringe. The illustration is labeled as Figure S and includes an arrow indicating the direction of movement.*

FDA Label Image

Ifu-fig-t (Ifu Fig T)

An instructional illustration showing a hand disposing of a used needle or syringe into a red sharps container labeled "SHARPS CONTAINER." A downward arrow indicates the direction of disposal into the container. This figure is likely related to safe sharps disposal instructions.*

FDA Label Image

Ifu-fig-u (Ifu Fig U)

An instructional illustration labeled 'Figure U' demonstrating the removal of a protective cap from a prefilled syringe used for subcutaneous injection of teriparatide 250 mcg/mL solution by Alvogen, Inc. The hands show grasping and pulling actions to detach the cap.*

FDA Label Image

Ifu-fig-v (Ifu Fig V)

An instructional diagram illustrating the insertion of a pen injector device into a vertical refrigerator door compartment, showing the device being placed inside for storage, indicated by an arrow pointing towards the refrigerator.*

FDA Label Image

Ifu-important-info (Ifu Important Info)

FDA Label Image

Ifu-ts-problem-a (Ifu Ts Problem A)

An instructional illustration showing a pen-style injection device with a red prohibition symbol overlay, indicating not to perform a certain action involving the injection pen. The pen is teal with a black cap and a yellow-red button or mechanism.*

FDA Label Image

Pen-label (Pen Label)

Label for Teriparatide Injection 250 mcg/mL solution for injection, with a total volume of 2.48 mL delivering 20 mcg per dose. It is for subcutaneous use only and distributed by Alvogen, Inc. The label includes storage instructions to refrigerate and not freeze, along with a barcode and usage warnings in red text.*

FDA Label Image

Amino-acid-sequence (Teriparatide)

Chemical structure diagram of teriparatide, displaying its amino acid sequence arranged in a linear chain with labeled residues from the N-terminus (H-) to the C-terminus (-OH).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.